.png "beLAB2122: translating excellent academic science into first-in-class therapeutics")
Registration
Attendee
Registration ended: 2022-12-12 19:00
ended
Event description
beLAB2122: translating excellent academic science into first-in-class therapeutics
with James Carmichael, Bristol Myers Squibb & Thomas Hanke, Evotec
We welcome you to the first on site meeting to introduce you to beLAB2122, a multi-year partnership between leading academic institutions in the Rhine-Main-Neckar area, Evotec and Bristol Myers Squibb.
Learn on how beLAB2122 can support you with your translational drug discovery ideas and discuss with the speakers afterwards at a short informal reception.
Location: Physikalisches Institut, Konferenzraum 1-3, Im Neuenheimer Feld 226, Heidelberg
Time: 12th December, 17:30 hrs
with James Carmichael, Bristol Myers Squibb & Thomas Hanke, Evotec
We welcome you to the first on site meeting to introduce you to beLAB2122, a multi-year partnership between leading academic institutions in the Rhine-Main-Neckar area, Evotec and Bristol Myers Squibb.
Learn on how beLAB2122 can support you with your translational drug discovery ideas and discuss with the speakers afterwards at a short informal reception.
Location: Physikalisches Institut, Konferenzraum 1-3, Im Neuenheimer Feld 226, Heidelberg
Time: 12th December, 17:30 hrs
Date & Location
Start:
2022-12-12 17:30
End:
2022-12-12 19:00
Im Neuenheimer Feld 226, 69120 Heidelberg
Registration website:https://belab2122-event-2022.konfeo.com
Share with friends
Organizer
supported by BioRN Life Science Cluster Rhine-Neckar